Literatur
-
1
Lagergren J, Bergstrom R, Lindgren A. et al .
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
N Engl J Med.
1999;
340
825-831
-
2
Cameron A, Lomboy C.
Barrett’s esophagus: age, prevalence, and extent of columnar epithelium.
Gastroenterology.
1992;
103
1241-1245
-
3
Bonelli L.
Barrett’s esophagus: results of a multicenter survey.
Endoscopy.
1993;
25 (suppl)
652-654
-
4
Robinson M, Earnest D, Rodriguez-Stanley S. et al .
Heartburn requiring frequent antacid use may indicate significant illness.
Arch Intern Med.
1998;
158
2373-2376
-
5
Gerson L, Shetler K, Triadafilopoulos G.
Prevalence of Barrett’s esophagus in asymptomatic individuals.
Gastroenterology.
2002;
123
461-467
-
6
Shaheen N, Crosby M, Bozymski E. et al .
Is there a publication bias in the reporting of cancer risk in Barrett’s esophagus?.
Gastroenterology.
2000;
119
333-338
-
7
Blot W, McLaughlin J.
The changing epidemiology of esophageal cancer.
Semin Oncol.
1999;
26 (suppl 15)
2-8
-
8
Sabik J, Rice T, Goldblum J. et al .
Superficial esophageal carcinoma.
Ann Thorac Surg.
1995;
60
896-902
-
9
Sampliner R.
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology.
Am J Gastroenterol.
2002;
97
1888-1895
-
10
Sonnenberg A, Soni A, Sampliner R.
Medical decision analysis of endoscopic surveillance of Barrett’s oesophagus to prevent oesophageal adenocarcinoma.
Aliment Pharmacol Ther.
2002;
16
41-50
-
11
Wright T, Gray M, Morris A. et al .
Cost effectiveness of detecting Barrett’s cancer.
Gut.
1996;
39
574-579
-
12
Van Sandick J, Lanschot J v, Kuiken B. et al .
Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma.
Gut.
1998;
43
216-222
-
13
Bani-Hani K, Sue-Ling H, Johnston D. et al .
Barrett’s oesophagus: results from a 13-year surveillance programme.
Eur J Gastroenterol Hepatol.
2000;
12
649-654
-
14
Thomas P, Doddoli C, Lienne P. et al .
Changing patterns and surgical results in adenocarcinoma of the oesophagus.
Br J Surg.
1997;
84
119-125
-
15
Sackett D.
Bias in analytic research.
J Chronic Dis.
1979;
32
51-63
-
16
Dulai G.
Surveying the case for surveillance.
Gastroenterology.
2002;
122
820-825
-
17
Dulai G, Guha S, Kahn K. et al .
Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review.
Gastroenterology.
2002;
122
26-33
-
18
Provenzale D, Schmitt C, Wong J.
Barrett’s esophagus: A new look at surveillance based on emerging estimates of cancer risk.
Am J Gastroenterol.
1999;
94
2043-2053
-
19
Endlicher E, Ruemmele P, Beer S. et al .
Endoscopic and histologic diagnosis of Long- and Short-Barrett’s esophagus.
Gastrointest Endosc.
2002;
55
AB203
-
20
Cameron A, Kamath P, Carpenter H.
Barrett’s esophagus: The prevalence of short and long segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy.
Gastroenterology.
1995;
91
A65
-
21
Ott R, Roesch TJM, Birkner B. et al .
Much ado about the „ultrashort” Barrett esophagus? Results from the munich multicenter study.
Gastroenterology.
1999;
116
A275
-
22
Weston A, Krmpotich P, Makdisi W. et al .
Short segment Barrett’s esophagus: Clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia.
Am J Gastroenterol.
1996;
91
981-986
-
23
Winters C J, Spurling T, Chobanian S. et al .
Barrett’s esophagus: a prevalent occult complication of gastroesophageal reflux disease.
Gastroenterology.
1987;
92
118-124
-
24
Eloubeidi M, Provenzale D.
Does this patient have Barrett’s esophagus? The Utility of predicting Barrett’s esophagus at the index endoscopy.
Am J Gastroenterol.
1999;
94
937-943
-
25
Seitz G, Vieth M, Stolte M.
Does endoscopically negative Barrett’s mucosa really exist?.
Gastrointest Endosc.
2002;
55
AB203
-
26
Weinstein W, Leh W, Lewin K. et al .
How often is short segement Barrett’s esophagus proven histologically? A prospective study.
Gastroenterology.
2002;
122 (suppl)
A293
-
27
Voutilainen M, Färkkilä M, Juhola M. et al .
Specialized columnar epithelium of the esophagogastric junction: prevalence and associations.
Am J Gastroenterol.
1999;
94
913-918
-
28
Nandurkar S, Talley N, Martin C. et al .
Short segment Barrett’s oesophagus: prevalence, diagnosis and associations.
Gut.
1997;
40
710-715
-
29
Canto M, Setrakian S, Willis J. et al .
Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus.
Gastrointest Endosc.
2000;
51
560-568
Dr. E. Endlicher
Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg
93042 Regensburg
Email: esther.endlicher@klinik.uni-regensburg.de
